(Q39068563)

8 September 2017

title

Pediatric Autoimmune Epileptic Encephalopathies (English)

1 reference

8 September 2017

Angela Vincent

1 reference

8 September 2017

Sukhvir Wright

1 reference

8 September 2017

publication date

1 January 2016

1 reference

Journal of Child Neurology

8 September 2017

published in

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

418-428

1 reference

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Epileptic encephalopathies: Optimizing seizure control and developmental outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited impact on developmental outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Inflammatory pathways of seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

The role of inflammation in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Role of inflammatory mediators in the pathogenesis of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Focal seizures due to chronic localized encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Epilepsy: an autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Population-level evidence for an autoimmune etiology of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Recent advances in the pharmacotherapy of infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-brain but not celiac disease antibodies in Landau-Kleffner syndrome and related epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Immune-mediated epilepsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Intravenous methylprednisolone for intractable childhood epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Effectiveness of a hybrid corticosteroid treatment regimen on refractory childhood seizures and a review of other corticosteroid treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Efficacy and tolerability of methylprednisolone pulse therapy in childhood epilepsies other than infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Synaptic plasticity: LTP and LTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

N-methyl-d-aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Late onset autism and anti-NMDA-receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

A clinical approach to diagnosis of autoimmune encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paraneoplastic syndromes and autoimmune encephalitis: Five new things.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoimmune post-herpes simplex encephalitis of adults and teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Potassium channel antibodies in two patients with reversible limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Morvan syndrome: clinical and serological observations in 29 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Neuronal voltage-gated potassium channel complex autoimmunity in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Limbic encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Clinical relevance of voltage-gated potassium channel–complex antibodies in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

GABAB receptor autoantibody frequency in service serologic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-NMDA receptor encephalitis: Pathogenic mechanisms and treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to AMPA receptors in Rasmussen's encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Neuronal autoantigens--pathogenesis, associated disorders and antibody testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Update on neurological paraneoplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Treatment of acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Serum antibodies in epilepsy and seizure-associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Antibodies to voltage-gated potassium and calcium channels in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoimmune epilepsy in children: case series and proposed guidelines for identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Autoimmune epilepsy: clinical characteristics and response to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073816685505

21 January 2018

Identifiers

DOI

10.1177/0883073816685505

1 reference

release_oberqgfmxvdq5dsfpguzuahcwy

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oberqgfmxvdq5dsfpguzuahcwy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference